Showing results (1531-1540 of 1,859) with videos related to
Sort By:
Pageof 186
Journal of the Society for Health Systems|October 24, 1998
Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation modelR H Tomar, S Lee, S Y Wu, et al.Diabetes Care|March 27, 2026
Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled AnalysisKlara R Klein, Anna Menacher, John B Buse, et al.BMC Plant Biology|January 28, 2009
A consensus genetic map of sorghum that integrates multiple component maps and high-throughput Diversity Array Technology (DArT) markersEmma S Mace, Jean-Francois Rami, Sophie Bouchet, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Local interleukin-2 therapy in bovine ocular squamous cell carcinoma. A pilot studyV P Rutten, W R Klein, W A De Jong, et al.Journal of Bacteriology|January 22, 2005
Characterization of the pheromone response of the Enterococcus faecalis conjugative plasmid pCF10: complete sequence and comparative analysis of the transcriptional and phenotypic responses of pCF10-containing cells to pheromone inductionHelmut Hirt, Dawn A Manias, Edward M Bryan, et al.The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.The Review of Scientific Instruments|November 29, 2014
Investigation of the hard x-ray background in backlit pinhole imagersJ R Fein, J L Peebles, P A Keiter, et al.Anticancer Research|November 1, 1993
Low doses of interleukin-2 can cure large bovine ocular squamous cell carcinomaW Den Otter, F W Hill, W R Klein, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2003
Comparison of the efficacy of local treatment of equine sarcoids with IL-2 or cisplatin/IL-2T J P Spoormakers, W R Klein, J J L Jacobs, et al.Biochemical and Biophysical Research Communications|December 16, 1987
The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibinD M Robertson, R Klein, F L de Vos, et al.Pageof 186